8 research outputs found

    A influência do estímulo precoce para aquisição dos marcos do desenvolvimento motor em crianças com Síndrome de Down

    Get PDF
    A Síndrome de Down (SD) é uma modificação genética produzida pela presença de um cromossomo a mais no par 21, conhecida também como trissomia 21. Algumas características presentes na Síndrome de Down, podem interferir no desenvolvimento motor. A estimulação precoce direcionado a bebês e crianças de até 3 anos que apresentam risco ou atraso no desenvolvimento neuropsicomotor que tem como objetivo facilitar e corrigir o desenvolvimento anormal por meio de diversos estímulos sensoriais, motores e cognitivos. Objetivo: Analisar os estudos referentes à estimulação precoce em crianças com Síndrome de Down para esclarecer sua influência no desenvolvimento motor dessas crianças. Metodologia: Trata-se de uma revisão bibliográfica. Resultados: As crianças com Síndrome de Down são capazes atingir os marcos sem grandes intervalos quando comprado com crianças típicas, de forma que sejam inseridas na estimulação precoce desde os primeiros meses de vida

    A reeducação postural global como método terapêutico para o tratamento de Escoliose: revisão de literatura / Global postural re-education as a therapeutic method for the treatment of Scoliosis: a literature review

    Get PDF
    Os métodos de reeducação postural global (RPG), têm sido usados na prática clínica na prevenção e restauração de doenças musculoesqueléticas e redução da escoliose. No processo de utilização do RPG, são utilizadas uma ou mais posturas que alongam gradativamente músculos específicos de uma determinada corrente e/ou cadeias estáticas secundárias. Objetivo: analisar a reeducação postural global como método terapêutico para o tratamento de escoliose. Metodologia: Esse trabalho trata-se de uma revisão de literatura, Scopus e Scientific Electronic Library Online (SCIELO), Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS) e Biblioteca virtual da saúde (BVS). Resultado e Discussão: Este estudo demonstra que a abordagem RPG é uma ferramenta eficaz para promover a redução da escoliose. Conclusão: Os benefícios obtidos na literatura, pode-se observar a importância da fisioterapia utilizando RPG especificamente para o tratamento de pacientes com escoliose, outros pesquisadores devem continuar buscando conhecimento para descobrir mais benefícios do RPG no tratamento da escoliose

    Avaliação da capacidade funcional em crianças com cardiopatia congênita: revisão integrativa da literatura: Functional capacity assessment in children with congenital heart disease: an integrative literature review

    Get PDF
    Introdução: A doença cardíaca congênita (DCC) é considerada um importante problema de saúde, alguns dos quais não afetam seriamente o cotidiano da criança, enquanto outros são mais graves, limitando a capacidade funcional e prejudicando a qualidade de vida, portanto, na maioria dos casos, e nestes um momento da vida da criança. Objetivo: demonstrar por meio de revisão integrativa de literatura uma avaliação da capacidade funcional em crianças com cardiopatia congênita. Métodos: A revisão de literatura foi realizada por meio das seguintes plataformas de busca nas bases de dados digitais científicas: Scielo, Medline e Pedro. Resultados: Do total de artigos estudados para atingir os objetivos propostos neste estudo, foram realizadas 94 Do total de artigos estudados para atingir os objetivos propostos neste estudo, foram realizadas 94 revisões de literatura, 50 foram descartadas, foram utilizados 44 artigos publicados entre 2012 e 2022, e temas relacionados ao desenvolvimento foram incluídos no artigo. Correspondendo: 4 pesquisas transversal, 1 pesquisa qualitativa, 7 revisões sistemática e 1 pesquisa ecocardiográfico totalizando 13 trabalhos. Considerações finais: O presente trabalho possibilitou uma análise por meio de avaliação de literatura sobre a capacidade funcional em crianças com cardiopatia congênita, de acordo com a bibliografia revisada, considera-se essencial a atuação do fisioterapeuta em todas as fases de reabilitação cardiopulmonar congênita

    Terapia manual aplicada em pacientes submetidos a artroplastia total de joelho: uma revisão de literatura: Manual therapy applied to patients undergoing total knee arthroplasty: a literature review

    Get PDF
    Nos últimos dez anos, um grande progresso foi feito na pesquisa de doenças existentes nas articulações do joelho, e várias técnicas cirúrgicas e muitas opções de tratamento surgiram, especialmente a artroplastia total do joelho. A artroplastia total do joelho substitui a articulação e os côndilos femorais e os côndilos tibiais por um componente metálico através de um implante protético, possui uma base metálica de suporte de polietileno. Assim, a reabilitação fisioterapêutica na fase pós-artroplastia do joelho é imprescindível e extremamente fundamental para a boa recuperação do paciente, sendo essencial que o fisioterapeuta tenha boa experiência nesta área. Objetivo: Analisar a terapia manual aplicada em pacientes submetidos a artroplastia total de joelho. Metodologia: os métodos trata-se de uma revisão de literatura integrativa, a base de dados de pesquisa do presente trabalho é: Scielo; Bireme e BVS. Resultados: a fisioterapia essencial nas fases iniciais do tratamento tem mostrado excelentes resultados. A eficácia da fisioterapia em fases posteriores fora do ambiente hospitalar. Considerando que os protocolos estabelecidos tratam de procedimentos que serão utilizados logo após a cirurgia, o objetivo é a recuperação mais rápida e, assim, restabelecer a qualidade de vida desses indivíduos. Considerações finais: Os benefícios para os pacientes de recursos terapêuticos manuais são claros, mesmo que essas terapias se mostrem benéficas; a literatura estudada sugere que mais pesquisas nessa área são necessárias com o objetivo de desenvolver opções de tratamento específicas

    Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

    Get PDF
    Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

    Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

    No full text
    Background: In early 2020, COVID-19 massively hit Italy, earlier and harder than any other European country. This caused a series of strict containment measures, aimed at blocking the spread of the pandemic. Healthcare delivery was also affected when resources were diverted towards care of COVID-19 patients, including intensive care wards. Aim of the study: The aim is assessing the impact of COVID-19 on cardiac imaging in Italy, compare to the Rest of Europe (RoE) and the World (RoW). Methods: A global survey was conducted in May–June 2020 worldwide, through a questionnaire distributed online. The survey covered three periods: March and April 2020, and March 2019. Data from 52 Italian centres, a subset of the 909 participating centres from 108 countries, were analyzed. Results: In Italy, volumes decreased by 67% in March 2020, compared to March 2019, as opposed to a significantly lower decrease (p &lt; 0.001) in RoE and RoW (41% and 40%, respectively). A further decrease from March 2020 to April 2020 summed up to 76% for the North, 77% for the Centre and 86% for the South. When compared to the RoE and RoW, this further decrease from March 2020 to April 2020 in Italy was significantly less (p = 0.005), most likely reflecting the earlier effects of the containment measures in Italy, taken earlier than anywhere else in the West. Conclusions: The COVID-19 pandemic massively hit Italy and caused a disruption of healthcare services, including cardiac imaging studies. This raises concern about the medium- and long-term consequences for the high number of patients who were denied timely diagnoses and the subsequent lifesaving therapies and procedures

    International Impact of COVID-19 on the Diagnosis of Heart Disease

    No full text
    Background: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. Objectives: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. Methods: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. Results: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p &lt; 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. Conclusions: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted

    Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

    No full text
    Objectives: The INCAPS COVID Oceania study aimed to assess the impact caused by the COVID-19 pandemic on cardiac procedure volume provided in the Oceania region. Methods: A retrospective survey was performed comparing procedure volumes within March 2019 (pre-COVID-19) with April 2020 (during first wave of COVID-19 pandemic). Sixty-three (63) health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, and 846 facilities outside of Oceania. The percentage change in procedure volume was measured between March 2019 and April 2020, compared by test type and by facility. Results: In Oceania, the total cardiac diagnostic procedure volume was reduced by 52.2% from March 2019 to April 2020, compared to a reduction of 75.9% seen in the rest of the world (p&lt;0.001). Within Oceania sites, this reduction varied significantly between procedure types, but not between types of health care facility. All procedure types (other than stress cardiac magnetic resonance [CMR] and positron emission tomography [PET]) saw significant reductions in volume over this time period (p&lt;0.001). In Oceania, transthoracic echocardiography (TTE) decreased by 51.6%, transoesophageal echocardiography (TOE) by 74.0%, and stress tests by 65% overall, which was more pronounced for stress electrocardiograph (ECG) (81.8%) and stress echocardiography (76.7%) compared to stress single-photon emission computerised tomography (SPECT) (44.3%). Invasive coronary angiography decreased by 36.7% in Oceania. Conclusion: A significant reduction in cardiac diagnostic procedure volume was seen across all facility types in Oceania and was likely a function of recommendations from cardiac societies and directives from government to minimise spread of COVID-19 amongst patients and staff. Longer term evaluation is important to assess for negative patient outcomes which may relate to deferral of usual models of care within cardiology
    corecore